                         SEQUENCE LISTING

<110>  THE CLEVELAND CLINIC FOUNDATION
 
<120>  INHIBITING CONNEXIN 46 TO TREAT GLIOBLASTOMA AND OTHER CONDITIONS

<130>  CCF-35438/WO-1/ORD

<150>  US 62/560,251
<151>  2017-09-19

<150>  US 62/644,687
<151>  2018-03-19

<160>  20    

<170>  PatentIn version 3.5

<210>  1
<211>  39
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic DNA Primer

<400>  1
agctttctgg gaagactctc agaaaatgca caggagcac                              39


<210>  2
<211>  39
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic DNA Primer

<400>  2
gtgctcctgt gcattttctg agagtcttcc cagaaagct                              39


<210>  3
<211>  39
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic DNA Primer

<400>  3
aatgcacagg agcactccat ggtcatcggc aaggtttgg                              39


<210>  4
<211>  39
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic DNA Primer

<400>  4
ccaaaccttg ccgatgacca tggagtgctc ctgtgcatt                              39


<210>  5
<211>  39
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic DNA Primer

<400>  5
gagcagtcag acttcaccgc caacacccag cagccgggc                              39


<210>  6
<211>  39
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic DNA Primer

<400>  6
gcccggctgc tgggtgttgg cggtgaagtc tgactgctc                              39


<210>  7
<211>  39
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic DNA Primer

<400>  7
aacacccagc agccgggcgc cgagaacgtc tgctacgac                              39


<210>  8
<211>  39
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic DNA Primer

<400>  8
gtcgtagcag acgttctcgg cgcccggctg ctgggtgtt                              39


<210>  9
<211>  39
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic DNA Primer

<400>  9
ccgggcgccg agaacgtcgc ctacgacagg gccttcccc                              39


<210>  10
<211>  39
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic DNA Primer

<400>  10
ggggaaggcc ctgtcgtagg cgacgttctc ggcgcccgg                              39


<210>  11
<211>  39
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic DNA Primer

<400>  11
ctgaagccgc tctaccgcgc cgaccgctgg ccctgcccc                              39


<210>  12
<211>  39
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic DNA Primer

<400>  12
ggggcagggc cagcggtcgg cgcggtagag cggcttcag                              39


<210>  13
<211>  39
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic DNA Primer

<400>  13
cgcgccgacc gctggcccgc ccccaacacg gtggacgcc                              39


<210>  14
<211>  39
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic DNA Primer

<400>  14
ggcgtccacc gtgttggggg cgggccagcg gtcggcgcg                              39


<210>  15
<211>  39
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic DNA Primer

<400>  15
gcccccaaca cggtggacgc cttcatctcc aggcccacg                              39


<210>  16
<211>  39
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic DNA Primer

<400>  16
cgtgggcctg gagatgaagg cgtccaccgt gttgggggc                              39


<210>  17
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic DNA Primer

<400>  17
caaaacgggc aattccactg                                                   20


<210>  18
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic DNA Primer

<400>  18
tgagcacagc atgtcacttg                                                   20


<210>  19
<211>  17
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic DNA Primer

<400>  19
tgcacaggag cactcca                                                      17


<210>  20
<211>  19
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic DNA Primer

<400>  20
gcgtggacac gaagatgat                                                    19


